{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:36:21Z","timestamp":1790642181930,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T00:00:00Z","timestamp":1541721600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1038\/s41416-018-0337-x","type":"journal-article","created":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T11:24:09Z","timestamp":1541417049000},"page":"1518-1526","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Prolyl-4-hydroxylase \u0391 subunit 2 (P4HA2) expression is a predictor of poor outcome in breast ductal carcinoma in situ (DCIS)"],"prefix":"10.1038","volume":"119","author":[{"given":"Michael S.","family":"Toss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Islam M.","family":"Miligy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylie L.","family":"Gorringe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulbaqi","family":"AlKawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazem","family":"Khout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian O.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad A.","family":"Rakha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,9]]},"reference":[{"key":"337_CR1","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ejca.2006.09.018","volume":"43","author":"A Ringberg","year":"2007","unstructured":"Ringberg, A. et al. Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast--results from the Swedish randomised trial. Eur. J. Cancer 43, 291\u2013298 (2007).","journal-title":"Eur. J. Cancer"},{"key":"337_CR2","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s10549-010-0912-1","volume":"124","author":"Y Liu","year":"2010","unstructured":"Liu, Y. et al. A longitudinal study of factors associated with perceived risk of recurrence in women with ductal carcinoma in situ and early-stage invasive breast cancer. Breast Cancer Res. Treat. 124, 835\u2013844 (2010).","journal-title":"Breast Cancer Res. Treat."},{"key":"337_CR3","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1093\/jnci\/djh164","volume":"96","author":"GD Leonard","year":"2004","unstructured":"Leonard, G. D. & Swain, S. M. Ductal carcinoma in situ, complexities and challenges. J. Natl. Cancer Inst. 96, 906\u2013920 (2004).2004\/06\/17.","journal-title":"J. Natl. Cancer Inst."},{"key":"337_CR4","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.breast.2016.09.001","volume":"31","author":"Emma J. Groen","year":"2017","unstructured":"Groen, E. J. et al. Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS). Breast 31, 274\u2013283(2016).","journal-title":"The Breast"},{"key":"337_CR5","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/modpathol.2015.79","volume":"28","author":"A Knopfelmacher","year":"2015","unstructured":"Knopfelmacher, A., Fox, J., Lo, Y., Shapiro, N. & Fineberg, S. Correlation of histopathologic features of ductal carcinoma in situ of the breast with the oncotype DX DCIS score. Mod. Pathol. 28, 1167\u20131173 (2015).","journal-title":"Mod. Pathol."},{"key":"337_CR6","unstructured":"Carraro, D. M., Elias, E. V. & Andrade, V. P. Ductal carcinoma in situ of the breast: morphological and molecular features implicated in progression. Biosci. Rep. 34, e00090 (2013)."},{"key":"337_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/978-81-322-2077-0","volume-title":"Breast Diseases","author":"Radhakrishna Selvi","year":"2015","unstructured":"Selvi, R. In: BreastDiseases: Imaging and Clinical Management 247\u2013249 (Springer India: New Delhi, 2015) https:\/\/doi.org\/10.1007\/978-81-322-2077-0 ."},{"key":"337_CR8","first-page":"512","volume":"13","author":"W Zhou","year":"2013","unstructured":"Zhou, W. et al. Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study. BMC Cancer (Res. Support, Non-U. S. Gov\u2019t) 13, 512 (2013).","journal-title":"BMC Cancer (Res. Support, Non-U. S. Gov\u2019t)"},{"key":"337_CR9","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/jnci\/djt067","volume":"105","author":"LJ Solin","year":"2013","unstructured":"Solin, L. J. et al. A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast. J. Natl. Cancer Inst. 105, 701\u2013710 (2013).","journal-title":"J. Natl. Cancer Inst."},{"key":"337_CR10","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1158\/1078-0432.CCR-13-1504","volume":"20","author":"MD Allen","year":"2014","unstructured":"Allen, M. D. et al. Altered microenvironment promotes progression of preinvasive breast cancer: myoepithelial expression of alphavbeta6 integrin in DCIS identifies high-risk patients and predicts recurrence. Clin. Cancer Res. 20, 344\u2013357 (2014).","journal-title":"Clin. Cancer Res."},{"key":"337_CR11","doi-asserted-by":"publisher","first-page":"236","DOI":"10.4161\/cam.20880","volume":"6","author":"A Boudreau","year":"2012","unstructured":"Boudreau, A., van\u2019t Veer, L. J. & Bissell, M. J. An \u201celite hacker\u201d: breast tumors exploit the normal microenvironment program to instruct their progression and biological diversity. Cell Adhes. Migr. 6, 236\u2013248 (2012).","journal-title":"Cell Adhes. Migr."},{"key":"337_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2222","volume":"11","author":"XJ Ma","year":"2009","unstructured":"Ma, X. J., Dahiya, S., Richardson, E., Erlander, M. & Sgroi, D. C. Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Res. 11, R7 (2009).","journal-title":"Breast Cancer Res."},{"key":"337_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/modpathol.2015.158","volume":"29","author":"E Thompson","year":"2016","unstructured":"Thompson, E. et al. The immune microenvironment of breast ductal carcinoma in situ. Mod. Pathol. 29, 249\u2013258 (2016).","journal-title":"Mod. Pathol."},{"issue":"3","key":"337_CR14","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nm.2328","volume":"17","author":"Mina J Bissell","year":"2011","unstructured":"Bissell, M. J., Hines, W. C. Why don\u2019t we get more cancer? a proposed role of the microenvironment in restraining cancer progression. Nat. Med. 17, 320\u2013329 (2011).","journal-title":"Nature Medicine"},{"key":"337_CR15","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3349\/ymj.2006.47.3.333","volume":"47","author":"HJ Kim","year":"2006","unstructured":"Kim, H. J., Park, C. I., Park, B. W., Lee, H. D. & Jung, W. H. Expression of MT-1 MMP, MMP2, MMP9 and TIMP2 mRNAs in ductal carcinoma in situ and invasive ductal carcinoma of the breast. Yonsei Med J. 47, 333\u2013342 (2006).","journal-title":"Yonsei Med J."},{"key":"337_CR16","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1126\/science.1067100","volume":"295","author":"LM Coussens","year":"2002","unstructured":"Coussens, L. M., Fingleton, B. & Matrisian, L. M. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295, 2387\u20132392 (2002). e-pub ahead of print 2002\/03\/30.","journal-title":"Science"},{"key":"337_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-4-38","volume":"4","author":"PP Provenzano","year":"2006","unstructured":"Provenzano, P. P. et al. Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med. 4, 38 (2006).","journal-title":"BMC Med."},{"issue":"1","key":"337_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0945-053X(03)00006-4","volume":"22","author":"Johanna Myllyharju","year":"2003","unstructured":"Myllyharju, J. Prolyl 4-hydroxylases, the key enzymes of collagen biosynthesis. Matrix Biol. 22, 15\u201324 (2003).","journal-title":"Matrix Biology"},{"key":"337_CR19","doi-asserted-by":"publisher","first-page":"4935","DOI":"10.1021\/pr200311p","volume":"10","author":"KP Chang","year":"2011","unstructured":"Chang, K. P. et al. Identification of PRDX4 and P4HA2 as metastasis-associated proteins in oral cavity squamous cell carcinoma by comparative tissue proteomics of microdissected specimens using iTRAQ technology. J. Proteome Res. 10, 4935\u20134947 (2011).","journal-title":"J. Proteome Res."},{"key":"337_CR20","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1158\/0008-5472.CAN-04-3078","volume":"65","author":"B Jarz\u0105b","year":"2005","unstructured":"Jarz\u0105b, B. et al. Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications. Cancer Res. 65, 1587\u20131597 (2005).","journal-title":"Cancer Res."},{"key":"337_CR21","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1158\/0008-5472.CAN-12-3963","volume":"73","author":"DM Gilkes","year":"2013","unstructured":"Gilkes, D. M. et al. Collagen prolyl hydroxylases are essential for breast cancer metastasis. Cancer Res. 73, 3285\u20133296 (2013).","journal-title":"Cancer Res."},{"key":"337_CR22","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1134\/S000629791205015X","volume":"77","author":"PW Pan","year":"2012","unstructured":"Pan, P. W., Zhang, Q., Bai, F., Hou, J. & Bai, G. Profiling and comparative analysis of glycoproteins in Hs578BST and Hs578T and investigation of prolyl 4-hydroxylase alpha polypeptide II expression and influence in breast cancer cells. Biochem. Biokhimiia 77, 539\u2013545 (2012).","journal-title":"Biochem. Biokhimiia"},{"key":"337_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-14-1","volume":"14","author":"G Xiong","year":"2014","unstructured":"Xiong, G., Deng, L., Zhu, J., Rychahou, P. G. & Xu, R. Prolyl-4-hydroxylase \u03b1 subunit 2 promotes breast cancer progression and metastasis by regulating collagen deposition. BMC Cancer 14, 1 (2014).","journal-title":"BMC Cancer"},{"key":"337_CR24","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1200\/JOP.777003","volume":"6","author":"ME Hammond","year":"2010","unstructured":"Hammond, M. E., Hayes, D. F., Wolff, A. C., Mangu, P. B. & Temin, S. American society of clinical oncology\/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J. Oncol. Pract. 6, 195\u2013197 (2010).","journal-title":"J. Oncol. Pract."},{"key":"337_CR25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1136\/jclinpath-2014-202571","volume":"68","author":"EA Rakha","year":"2015","unstructured":"Rakha, E. A. et al. Updated UK Recommendations for HER2 assessment in breast cancer. J. Clin. Pathol. 68, 93\u201399 (2015).","journal-title":"J. Clin. Pathol."},{"key":"337_CR26","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1309\/AJCP4M2VUZCLDALN","volume":"132","author":"Y Gong","year":"2009","unstructured":"Gong, Y. et al. Performance of chromogenic in situ hybridization on testing HER2 Status in breast carcinomas with chromosome 17 polysomy and equivocal (2\u2009+\u2009) herceptest results: a study of two institutions using the conventional and new ASCO\/CAP scoring criteria. Am. J. Clin. Pathol. 132, 228\u2013236 (2009).","journal-title":"Am. J. Clin. Pathol."},{"key":"337_CR27","unstructured":"Gilkes, D. M., Bajpai, S., Chaturvedi, P., Wirtz, D. & Semenza, G. L. Hypoxia-inducible factor 1 (HIF-1) promotes extracellular matrix remodeling under hypoxic conditions by inducing P4HA1, P4HA2, and PLOD2 expression in fibroblasts. J. Biol. Chem. 288, 10819 (2013)."},{"key":"337_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/srep43984","volume":"7","author":"K Mittal","year":"2017","unstructured":"Mittal, K. et al. Amplified centrosomes and mitotic index display poor concordance between patient tumors and cultured cancer cells. Sci. Rep. 7, 43984 (2017).","journal-title":"Sci. Rep."},{"key":"337_CR29","first-page":"297","volume":"1","author":"KS McCarty Jr","year":"1984","unstructured":"McCarty, K. S.Jr. & KS, Mc. Carty.Sr. Histochemical approaches to steroid receptor analyses. Semin. Diagn. Pathol. 1, 297\u2013308 (1984).","journal-title":"Semin. Diagn. Pathol."},{"issue":"17","key":"337_CR30","doi-asserted-by":"publisher","first-page":"5210","DOI":"10.1158\/1078-0432.CCR-17-0743","volume":"23","author":"Shona Hendry","year":"2017","unstructured":"Hendry, S. et al. Relationship of the breast ductal carcinoma in situ immune microenvironment with clinico-pathological and genetic features. Clin. Cancer Res. 23, 5210\u20135217 (2017).","journal-title":"Clinical Cancer Research"},{"key":"337_CR31","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp, R. L., Dolled-Filhart, M. & Rimm, D. L. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin. Cancer Res. 10, 7252\u20137259 (2004).","journal-title":"Clin. Cancer Res."},{"key":"337_CR32","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis, C. et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486, 346\u2013352 (2012).","journal-title":"Nature"},{"key":"337_CR33","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0002-9610(03)00265-4","volume":"186","author":"MJ Silverstein","year":"2003","unstructured":"Silverstein, M. J. The University of Southern California\/Van Nuys prognostic index for ductal carcinoma in situ of the breast. Am. J. Surg. 186, 337\u2013343 (2003).","journal-title":"Am. J. Surg."},{"key":"337_CR34","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13058-015-0623-y","volume":"17","author":"A Afghahi","year":"2015","unstructured":"Afghahi, A. et al. Chromosomal copy number alterations for associations of ductal carcinoma in situ with invasive breast cancer. Breast Cancer Res. 17, 108 (2015).","journal-title":"Breast Cancer Res."},{"key":"337_CR35","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3389\/fonc.2017.00248","volume":"7","author":"KL Gorringe","year":"2017","unstructured":"Gorringe, K. L. & Fox, S. B. Ductal carcinoma in situ biology, biomarkers, and diagnosis. Front. Oncol. 7, 248 (2017).","journal-title":"Front. Oncol."},{"key":"337_CR36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ccr.2004.06.010","volume":"6","author":"M Allinen","year":"2004","unstructured":"Allinen, M. et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell. 6, 17\u201332 (2004).","journal-title":"Cancer Cell."},{"key":"337_CR37","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ccr.2008.03.007","volume":"13","author":"M Hu","year":"2008","unstructured":"Hu, M. et al. Regulation of in situ to invasive breast carcinoma transition. Cancer Cell. 13, 394\u2013406 (2008).","journal-title":"Cancer Cell."},{"key":"337_CR38","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10911-014-9326-8","volume":"19","author":"A Unsworth","year":"2014","unstructured":"Unsworth, A., Anderson, R. & Britt, K. Stromal fibroblasts and the immune microenvironment: partners in mammary gland biology and pathology?. J. Mammary Gland Biol. Neoplasia 19, 169\u2013182 (2014).","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"337_CR39","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1158\/0008-5472.CAN-10-0538","volume":"71","author":"S Liu","year":"2011","unstructured":"Liu, S. et al. Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks. Cancer Res. 71, 614\u2013624 (2011).","journal-title":"Cancer Res."},{"key":"337_CR40","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1016\/j.yexcr.2010.07.002","volume":"316","author":"Y Rattigan","year":"2010","unstructured":"Rattigan, Y., Hsu, J. M., Mishra, P. J., Glod, J. & Banerjee, D. Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu. Exp. Cell Res. 316, 3417\u20133424 (2010).","journal-title":"Exp. Cell Res."},{"key":"337_CR41","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"337_CR42","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature06188","volume":"449","author":"AE Karnoub","year":"2007","unstructured":"Karnoub, A. E. et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449, 557\u2013563 (2007).","journal-title":"Nature"},{"key":"337_CR43","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1083\/jcb.201102147","volume":"196","author":"P Lu","year":"2012","unstructured":"Lu, P., Weaver, V. M. & Werb, Z. The extracellular matrix: a dynamic niche in cancer progression. J. Cell Biol. 196, 395\u2013406 (2012).","journal-title":"J. Cell Biol."},{"key":"337_CR44","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.ajpath.2010.11.076","volume":"178","author":"MW Conklin","year":"2011","unstructured":"Conklin, M. W. et al. Aligned collagen is a prognostic signature for survival in human breast carcinoma. Am. J. Pathol. 178, 1221\u20131232 (2011).","journal-title":"Am. J. Pathol."},{"key":"337_CR45","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ceb.2009.05.004","volume":"21","author":"K Raymond","year":"2009","unstructured":"Raymond, K., Deugnier, M. A., Faraldo, M. M. & Glukhova, M. A. Adhesion within the stem cell niches. Curr. Opin. Cell Biol. 21, 623\u2013629 (2009).","journal-title":"Curr. Opin. Cell Biol."},{"key":"337_CR46","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.stem.2008.07.026","volume":"3","author":"Q Shen","year":"2008","unstructured":"Shen, Q. et al. Adult SVZ stem cells lie in a vascular niche: a quantitative analysis of niche cell-cell interactions. Cell. Stem. Cell. 3, 289\u2013300 (2008).","journal-title":"Cell. Stem. Cell."},{"key":"337_CR47","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.ceb.2009.07.003","volume":"21","author":"ME Feigin","year":"2009","unstructured":"Feigin, M. E. & Muthuswamy, S. K. Polarity proteins regulate mammalian cell-cell junctions and cancer pathogenesis. Curr. Opin. Cell Biol. 21, 694\u2013700 (2009).","journal-title":"Curr. Opin. Cell Biol."},{"key":"337_CR48","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/nrc1231","volume":"3","author":"J Condeelis","year":"2003","unstructured":"Condeelis, J. & Segall, J. E. Intravital imaging of cell movement in tumours. Nat. Rev. Cancer 3, 921\u2013930 (2003).","journal-title":"Nat. Rev. Cancer"},{"key":"337_CR49","first-page":"6278","volume":"62","author":"W Wang","year":"2002","unstructured":"Wang, W. et al. Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profiling. Cancer Res. 62, 6278\u20136288 (2002).","journal-title":"Cancer Res."},{"key":"337_CR50","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.tcb.2009.08.009","volume":"19","author":"PP Provenzano","year":"2009","unstructured":"Provenzano, P. P., Eliceiri, K. W. & Keely, P. J. Shining new light on 3D cell motility and the metastatic process. Trends Cell Biol. 19, 638\u2013648 (2009).","journal-title":"Trends Cell Biol."},{"issue":"Pt 2","key":"337_CR51","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1242\/jcs.108.2.595","volume":"108","author":"PJ Keely","year":"1995","unstructured":"Keely, P. J., Fong, A. M., Zutter, M. M. & Santoro, S. A. Alteration of collagen-dependent adhesion, motility, and morphogenesis by the expression of antisense alpha 2 integrin mRNA in mammary cells. J. Cell Sci. 108 (Pt 2), 595\u2013607 (1995).","journal-title":"J. Cell Sci."},{"key":"337_CR52","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.bbamcr.2015.05.036","volume":"1863","author":"GL Semenza","year":"2016","unstructured":"Semenza, G. L. The hypoxic tumor microenvironment: A driving force for breast cancer progression. Biochim. Biophys. Acta 1863, 382\u2013391 (2016).","journal-title":"Biochim. Biophys. Acta"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41416-018-0337-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-018-0337-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-018-0337-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:03:48Z","timestamp":1684616628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-018-0337-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,9]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["337"],"URL":"https:\/\/doi.org\/10.1038\/s41416-018-0337-x","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,9]]},"assertion":[{"value":"17 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The datasets generated during and\/or analysed during the current study are available from the corresponding authors on reasonable request.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"This research was supported and funded by the Egyptian Ministry of Higher Education and Scientific Research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"This work obtained ethics approval by the North West \u2013 Greater Manchester Central Research Ethics Committee under the title; Nottingham Health Science Biobank (NHSB), reference number 15\/NW\/0685.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Note"}}]}}